Basic Information
RNALocate ID: | RLID:11000741 |
RNA Symbol: | hsa-miR-20a-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-20a-5p |
RNA ID: | miRBase:MIMAT0000075 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22211110 |
Tissue/Cell Line: | Breast milk |
Method: | Next-generation RNA sequencing |
The expression profile of selected miRNAs in breast milk exosomes. Originally published in Int J Biol Sci. Zhou Q, et al, 2012. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Distribution and characterization of miRNAs in breast milk exosomes. (A) Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). χ2 test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten well-characterized tissue-specific pre-miRNAs. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001294 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01001295 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001296 | Cytoplasm | HeLa cells | 23940654 |
RLID:01001297 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001298 | Mitochondrion | Myotube | 27396686 |
RLID:01001299 | Mitochondrion | Skeletal muscle cells | 27563705 |
RLID:01001300 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001301 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001302 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001303 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
RLID:01001304 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11000737 | Exosome | Sera | 24978137 |
RLID:11000738 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
RLID:11000739 | Exosome | Glioblastoma cells | 19011622 |
RLID:11000740 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000742 | Exosome | Brain tissue | 23382797 |
RLID:11000743 | Exosome | Plasma | 23663360 |
RLID:11000744 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000745 | Exosome | Serum | 25349172 |
RLID:11000746 | Exosome | Cerebrospinal fluid | 25420022 |
RLID:11000747 | Extracellular Vesicle | Liposarcoma cell lines (Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
RLID:11000748 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11000749 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11000750 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000751 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000012 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Tongue tissue | |
RLID-D:11000274 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-20a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-27697 |
MNDR | hsa-miR-20a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-27698 |
MNDR | hsa-miR-20a-5p | Colorectal adenocarcinoma | MNDR-E-MI-27699 |
MNDR | hsa-miR-20a-5p | Oral squamous cell carcinoma | MNDR-E-MI-27700 |
MNDR | hsa-miR-20a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-27701 |
MNDR | hsa-miR-20a-5p | Medulloblastoma | MNDR-E-MI-27702 |
MNDR | hsa-miR-20a-5p | B cell lymphoma of malt type | MNDR-E-MI-27703 |
MNDR | hsa-miR-20a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-27704 |
MNDR | hsa-miR-20a-5p | Autism spectrum disorder | MNDR-E-MI-27705 |
MNDR | hsa-miR-20a-5p | Lymphoma | MNDR-E-MI-27706 |
MNDR | hsa-miR-20a-5p | Lymphoma non-hodgkin | MNDR-E-MI-27707 |
MNDR | hsa-miR-20a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-27708 |
MNDR | hsa-miR-20a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-27709 |
MNDR | hsa-miR-20a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-27710 |
MNDR | hsa-miR-20a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-27711 |
MNDR | hsa-miR-20a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-27712 |
MNDR | hsa-miR-20a-5p | Breast cancer luminal | MNDR-E-MI-27713 |
MNDR | hsa-miR-20a-5p | Niemann-pick disease type c | MNDR-E-MI-27714 |
MNDR | hsa-miR-20a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-27715 |
MNDR | hsa-miR-20a-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-27716 |
MNDR | hsa-miR-20a-5p | Dermatomyositis | MNDR-E-MI-27717 |
MNDR | hsa-miR-20a-5p | Prostate cancer | MNDR-E-MI-27718 |
MNDR | hsa-miR-20a-5p | Gastric cancer | MNDR-E-MI-27719 |
MNDR | hsa-miR-20a-5p | Gastric lymphoma | MNDR-E-MI-27720 |
MNDR | hsa-miR-20a-5p | Alzheimer disease | MNDR-E-MI-27721 |
MNDR | hsa-miR-20a-5p | Intracranial aneurysm | MNDR-E-MI-27722 |
MNDR | hsa-miR-20a-5p | Bladder cancer | MNDR-E-MI-27723 |
MNDR | hsa-miR-20a-5p | Esophageal carcinoma | MNDR-E-MI-27724 |
MNDR | hsa-miR-20a-5p | Dysautonomia familial | MNDR-E-MI-27725 |
MNDR | hsa-miR-20a-5p | Primary biliary cirrhosis | MNDR-E-MI-27726 |
MNDR | hsa-miR-20a-5p | Leukemia | MNDR-E-MI-27727 |
MNDR | hsa-miR-20a-5p | Ataxia telangiectasia | MNDR-E-MI-27728 |
MNDR | hsa-miR-20a-5p | Huntington disease | MNDR-E-MI-27729 |
MNDR | hsa-miR-20a-5p | Chorea | MNDR-E-MI-27730 |
MNDR | hsa-miR-20a-5p | Cardiovascular disease | MNDR-E-MI-27731 |
MNDR | hsa-miR-20a-5p | Carotid stenosis | MNDR-E-MI-27732 |
MNDR | hsa-miR-20a-5p | Moyamoya disease | MNDR-E-MI-27733 |
MNDR | hsa-miR-20a-5p | Lung cancer | MNDR-E-MI-27734 |
MNDR | hsa-miR-20a-5p | Down syndrome | MNDR-E-MI-27735 |
MNDR | hsa-miR-20a-5p | Parkinson disease | MNDR-E-MI-27736 |
MNDR | hsa-miR-20a-5p | Niemann-pick disease | MNDR-E-MI-27737 |
MNDR | hsa-miR-20a-5p | Colon carcinoma | MNDR-E-MI-27738 |
MNDR | hsa-miR-20a-5p | Basal-like breast cancer | MNDR-E-MI-27739 |
MNDR | hsa-miR-20a-5p | Squamous cell carcinoma | MNDR-E-MI-27740 |
MNDR | hsa-miR-20a-5p | Thyroid cancer | MNDR-E-MI-27741 |
MNDR | hsa-miR-20a-5p | Pituitary neoplasms | MNDR-E-MI-27742 |
MNDR | hsa-miR-20a-5p | Pancreatic cancer | MNDR-E-MI-27743 |
MNDR | hsa-miR-20a-5p | Melanoma | MNDR-E-MI-27744 |
MNDR | hsa-miR-20a-5p | Lesch-nyhan syndrome | MNDR-E-MI-27745 |
MNDR | hsa-miR-20a-5p | Rectum adenocarcinoma | MNDR-E-MI-27746 |
MNDR | hsa-miR-20a-5p | Nephroblastoma | MNDR-E-MI-27747 |
MNDR | hsa-miR-20a-5p | Colon cancer | MNDR-E-MI-27748 |
MNDR | hsa-miR-20a-5p | Ischemic attack transient | MNDR-E-MI-27749 |
MNDR | hsa-miR-20a-5p | Colon adenocarcinoma | MNDR-E-MI-27750 |
MNDR | hsa-miR-20a-5p | Multiple sclerosis | MNDR-E-MI-27751 |
MNDR | hsa-miR-20a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-27752 |
MNDR | hsa-miR-20a-5p | Ovarian cancer | MNDR-E-MI-27753 |
MNDR | hsa-miR-20a-5p | Prostate adenocarcinoma | MNDR-E-MI-27754 |
MNDR | hsa-miR-20a-5p | Kidney cancer | MNDR-E-MI-27755 |
MNDR | hsa-miR-20a-5p | Endometriosis | MNDR-E-MI-27756 |
MNDR | hsa-miR-20a-5p | Carcinoma ductal breast | MNDR-E-MI-27757 |
MNDR | hsa-miR-20a-5p | Glioblastoma | MNDR-E-MI-27758 |
MNDR | hsa-miR-20a-5p | Astrocytoma | MNDR-E-MI-27759 |
MNDR | hsa-miR-20a-5p | Glioma | MNDR-E-MI-27760 |
MNDR | hsa-miR-20a-5p | Oligodendroglioma | MNDR-E-MI-27761 |
MNDR | hsa-miR-20a-5p | Central nervous system lymphoma | MNDR-E-MI-27762 |
MNDR | hsa-miR-20a-5p | Chordoma | MNDR-E-MI-27763 |
MNDR | hsa-miR-20a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-27764 |
MNDR | hsa-miR-20a-5p | Epilepsy temporal lobe | MNDR-E-MI-27765 |
MNDR | hsa-miR-20a-5p | Osteosarcoma | MNDR-E-MI-27766 |
MNDR | hsa-miR-20a-5p | Liposarcoma | MNDR-E-MI-27767 |
MNDR | hsa-miR-20a-5p | Meningioma | MNDR-E-MI-27768 |
MNDR | hsa-miR-20a-5p | Liver cancer | MNDR-E-MI-27769 |
MNDR | hsa-miR-20a-5p | Uterine cancer | MNDR-E-MI-27770 |
MNDR | hsa-miR-20a-5p | Gastric adenocarcinoma | MNDR-E-MI-27771 |
MNDR | hsa-miR-20a-5p | Pituitary adenoma | MNDR-E-MI-27772 |
MNDR | hsa-miR-20a-5p | Lung squamous cell carcinoma | MNDR-E-MI-27773 |
MNDR | hsa-miR-20a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-27774 |
MNDR | hsa-miR-20a-5p | Lung adenocarcinoma | MNDR-E-MI-27775 |
MNDR | hsa-miR-20a-5p | Adrenocortical carcinoma | MNDR-E-MI-27776 |
MNDR | hsa-miR-20a-5p | Thyroid carcinoma | MNDR-E-MI-27777 |
MNDR | hsa-miR-20a-5p | Ovarian carcinoma | MNDR-E-MI-27778 |
MNDR | hsa-miR-20a-5p | Bladder urothelial carcinoma | MNDR-E-MI-27779 |
MNDR | hsa-miR-20a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-27780 |
MNDR | hsa-miR-20a-5p | Brain stem cancer | MNDR-E-MI-27781 |
MNDR | hsa-miR-20a-5p | Cervical cancer | MNDR-E-MI-27782 |
MNDR | hsa-miR-20a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-27783 |
MNDR | hsa-miR-20a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-27784 |
MNDR | hsa-miR-20a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-27785 |
MNDR | hsa-miR-20a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-27786 |
MNDR | hsa-miR-20a-5p | Biliary tract cancer | MNDR-E-MI-27787 |
MNDR | hsa-miR-20a-5p | Pancreatic carcinoma | MNDR-E-MI-27788 |
MNDR | hsa-miR-20a-5p | Cholangiocarcinoma | MNDR-E-MI-27789 |
MNDR | hsa-miR-20a-5p | Esophageal cancer | MNDR-E-MI-27790 |
MNDR | hsa-miR-20a-5p | Lung small cell carcinoma | MNDR-E-MI-27791 |
MNDR | hsa-miR-20a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-27792 |
MNDR | hsa-miR-20a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-27793 |
MNDR | hsa-miR-20a-5p | Acute t cell leukemia | MNDR-E-MI-27794 |
MNDR | hsa-miR-20a-5p | Pulmonary hypertension | MNDR-E-MI-27795 |
MNDR | hsa-miR-20a-5p | Adenoma | MNDR-E-MI-27796 |
MNDR | hsa-miR-20a-5p | Breast invasive carcinoma | MNDR-E-MI-27797 |
MNDR | hsa-miR-20a-5p | Early hepatocellular carcinoma | MNDR-E-MI-27798 |
MNDR | hsa-miR-20a-5p | B-cell lymphoma | MNDR-E-MI-27799 |
MNDR | hsa-miR-20a-5p | Rheumatoid arthritis | MNDR-E-MI-27800 |
MNDR | hsa-miR-20a-5p | T-cell leukemia | MNDR-E-MI-27801 |
MNDR | hsa-miR-20a-5p | Retinoblastoma | MNDR-E-MI-27802 |
MNDR | hsa-miR-20a-5p | Neuroblastoma | MNDR-E-MI-27803 |
MNDR | hsa-miR-20a-5p | Chronic myeloid leukemia | MNDR-E-MI-27804 |
MNDR | hsa-miR-20a-5p | Hodgkin disease | MNDR-E-MI-27805 |
MNDR | hsa-miR-20a-5p | Burkitt lymphoma | MNDR-E-MI-27806 |
MNDR | hsa-miR-20a-5p | Lymphosarcoma | MNDR-E-MI-27807 |
MNDR | hsa-miR-20a-5p | Neuromyelitis optica | MNDR-E-MI-27808 |
MNDR | hsa-miR-20a-5p | Psoriasis | MNDR-E-MI-27809 |
MNDR | hsa-miR-20a-5p | Acute myelogenous leukemia | MNDR-E-MI-27810 |
MNDR | hsa-miR-20a-5p | Colorectal cancer | MNDR-E-MI-27811 |
MNDR | hsa-miR-20a-5p | Multiple myeloma | MNDR-E-MI-27812 |
MNDR | hsa-miR-20a-5p | Acute lymphocytic leukemia | MNDR-E-MI-27813 |
MNDR | hsa-miR-20a-5p | Uterine cervical neoplasms | MNDR-E-MI-27814 |
MNDR | hsa-miR-20a-5p | Ependymoma | MNDR-E-MI-27815 |
MNDR | hsa-miR-20a-5p | Nasopharyngeal cancer | MNDR-E-MI-27816 |
MNDR | hsa-miR-20a-5p | Prostatic neoplasms | MNDR-E-MI-27817 |
MNDR | hsa-miR-20a-5p | Pseudorabies | MNDR-E-MI-27818 |
MNDR | hsa-miR-20a-5p | Arsenic poisoning | MNDR-E-MI-27819 |
MNDR | hsa-miR-20a-5p | Stroke lacunar | MNDR-E-MI-27820 |
MNDR | hsa-miR-20a-5p | Duke C | MNDR-E-MI-27821 |
MNDR | hsa-miR-20a-5p | High grade dysplastic nodule | MNDR-E-MI-27822 |
MNDR | hsa-miR-20a-5p | Tubulovillous adenoma | MNDR-E-MI-27823 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABL2 | Homo sapiens | RR00027165 |
TOP